Abstract
Background: Post-cardiopulmonary bypass (CPB) blood processing is an important component of blood management during cardiac surgery. Purpose: The purpose of this study is to evaluate several methods of processing post-CPB residual blood.
Research Design: Using a multi-institutional national database (SpecialtyCare Operative Procedural rEgistry [SCOPE]), 77,591 cardiac surgical operations performed in adults (>18 years) between January 2017 and September 2022 were reviewed.
Study Sample: Blood processing methods included: Cell washing (CW, n = 63,592), Ultrafiltration (UF, n = 6286), Whole blood (WB, n = 3749), Hemobag (HB, n = 2480), and No processing (NO, n = 1484). The primary outcome was intraoperative post-CPB allogenic red blood cell (RBC) transfusion.
Data Analysis: Group differences in RBC transfusion were assessed using a Bayesian mixed-effects logistic regression model controlling for multiple operative variables.
Results: Across blood processing groups, patients had similar ages, body mass index and surgical procedures performed as well as preoperative hematocrit and nadir operative hematocrit. Median hematocrit change from last-in-operating room to first-in-ICU were highest in UF and HB groups (3.0 [IQR = 2.0–4.8] and 2.5 [IQR = 0.4–5.0]), respectively. The model-predicted probability of intraoperative post-CPB RBC transfusion was lowest in the HB group (0.79% [95% CrI = 0.37%–1.26%]), and highest in NO group (2.12% [95% CrI = 1.47%–2.82%]). Relative to CW, the odds of RBC transfusion for HB cases were reduced by half (OR = 0.5 [95% CrI = 0.28–0.89], statistical reliability = 99.1%), while odds for NO were 1.41 greater (OR = 1.41 [95% CrI = 1.03–1.93], statistical reliability = 98.2%).
Conclusions: Post-CPB blood processing affects the likelihood for both receiving an intraoperative post-CPB RBC transfusion and for hematocrit change, with HB use resulting in the lowest predicted risk for transfusion, and NO the highest.
Get full access to this article
View all access options for this article.
